| Year |
Citation |
Score |
| 2022 |
Coenen VA, Schlaepfer TE, Sajonz BEA, Reinacher PC, Döbrössy MD, Reisert M. "The Heart Asks Pleasure First"-Conceptualizing Psychiatric Diseases as Network Dysfunctions through Insights from slMFB DBS in Depression and Obsessive-Compulsive Disorder. Brain Sciences. 12. PMID 35447971 DOI: 10.3390/brainsci12040438 |
0.331 |
|
| 2021 |
Hebel T, Grözinger M, Landgrebe M, Padberg F, Schecklmann M, Schlaepfer T, Schönfeldt-Lecuona C, Ullrich H, Zwanzger P, Langguth B, Bajbouj M, Bewernick B, Brinkmann K, Cordes J, et al. Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-36. PMID 34668449 DOI: 10.1080/15622975.2021.1995810 |
0.302 |
|
| 2020 |
Döbrössy MD, Ramanathan C, Ashouri Vajari D, Tong Y, Schlaepfer T, Coenen VA. Neuromodulation in Psychiatric disorders: Experimental and Clinical evidence for reward and motivation network Deep Brain Stimulation: Focus on the medial forebrain bundle. The European Journal of Neuroscience. PMID 32931064 DOI: 10.1111/Ejn.14975 |
0.467 |
|
| 2020 |
Coenen VA, Schlaepfer TE, Sajonz B, Döbrössy M, Kaller CP, Urbach H, Reisert M. Tractographic description of major subcortical projection pathways passing the anterior limb of the internal capsule. Corticopetal organization of networks relevant for psychiatric disorders. Neuroimage: Clinical. 25: 102165. PMID 31954987 DOI: 10.1016/J.Nicl.2020.102165 |
0.315 |
|
| 2020 |
Kilian HM, Bewernick BH, Klein M, Meyer DM, Spanier S, Reinacher PC, Coenen VA, Schlaepfer TE. Deep Brain Stimulation for Major Depression and Obsessive-Compulsive Disorder—Discontinuation of Ongoing Stimulation Psychology. 2: 174-185. DOI: 10.3390/Psych2030015 |
0.492 |
|
| 2019 |
Kayser S, Bewernick BH, Wagner S, Schlaepfer TE. Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment-resistant depression. Depression and Anxiety. PMID 31682325 DOI: 10.1002/Da.22958 |
0.38 |
|
| 2019 |
Coenen VA, Schlaepfer TE, Bewernick B, Kilian H, Kaller CP, Urbach H, Li M, Reisert M. Frontal white matter architecture predicts efficacy of deep brain stimulation in major depression. Translational Psychiatry. 9: 197. PMID 31434867 DOI: 10.1038/S41398-019-0540-4 |
0.443 |
|
| 2019 |
Coenen VA, Schlaepfer TE, Reinacher PC, Mast H, Urbach H, Reisert M. Machine learning-aided personalized DTI tractographic planning for deep brain stimulation of the superolateral medial forebrain bundle using HAMLET. Acta Neurochirurgica. 161: 1559-1569. PMID 31144167 DOI: 10.1007/S00701-019-03947-9 |
0.364 |
|
| 2019 |
Spanier S, Kilian HM, Meyer DM, Schlaepfer TE. Treatment resistance in major depression is correlated with increased plasma levels of neurofilament light protein reflecting axonal damage. Medical Hypotheses. 127: 159-161. PMID 31088642 DOI: 10.1016/J.Mehy.2019.03.022 |
0.381 |
|
| 2019 |
Coenen VA, Bewernick BH, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein ME, Spanier S, Sajonz B, Urbach H, Schlaepfer TE. Superolateral medial forebrain bundle deep brain stimulation in major depression: a gateway trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 30867553 DOI: 10.1038/S41386-019-0369-9 |
0.45 |
|
| 2019 |
Lozano AM, Lipsman N, Bergman H, Brown P, Chabardes S, Chang JW, Matthews K, McIntyre CC, Schlaepfer TE, Schulder M, Temel Y, Volkmann J, Krauss JK. Deep brain stimulation: current challenges and future directions. Nature Reviews. Neurology. PMID 30683913 DOI: 10.1038/S41582-018-0128-2 |
0.373 |
|
| 2019 |
Gippert S, Kilian H, Klein M, Hurlemann R, Coenen V, Schlaepfer T, Fliessbach K, Bewernick B. T108. The Effect of Deep Brain Stimulation of the Medial Forebrain Bundle on Reward Processing in Treatment-Resistant Depression- A Mode of Action Study Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.431 |
0.424 |
|
| 2019 |
Schlaepfer T, Kilian H, Bewernick B, Coenen V. 36. Long-Term Efficacy of Different Deep Brain Stimulation to Different Targets - What is the True Clinical Benefit? Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.050 |
0.331 |
|
| 2019 |
Coenen V, Schlaepfer T, Urbach H, Reisert M. 35. Frontal White Matter Architectural Network Changes Predict Therapeutic Deep Brain Stimulation for Major Depression Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.049 |
0.411 |
|
| 2018 |
Kilian HM, Meyer DM, Bewernick BH, Spanier S, Coenen VA, Schlaepfer TE. Discontinuation of Superolateral Medial Forebrain Bundle Deep Brain Stimulation for Treatment-Resistant Depression Leads to Critical Relapse. Biological Psychiatry. PMID 30253883 DOI: 10.1016/J.Biopsych.2018.07.025 |
0.469 |
|
| 2018 |
Coenen VA, Sajonz B, Reisert M, Bostroem J, Bewernick B, Urbach H, Jenkner C, Reinacher PC, Schlaepfer TE, Mädler B. Tractography-assisted deep brain stimulation of the superolateral branch of the medial forebrain bundle (slMFB DBS) in major depression Neuroimage: Clinical. 20: 580-593. PMID 30186762 DOI: 10.1016/J.Nicl.2018.08.020 |
0.42 |
|
| 2018 |
Coenen VA, Schumacher LV, Kaller C, Schlaepfer TE, Reinacher PC, Egger K, Urbach H, Reisert M. The anatomy of the human medial forebrain bundle: Ventral tegmental area connections to reward-associated subcortical and frontal lobe regions. Neuroimage: Clinical. 18: 770-783. PMID 29845013 DOI: 10.1016/J.Nicl.2018.03.019 |
0.33 |
|
| 2018 |
Kayser S, Bewernick BH, Wagner S, Schlaepfer TE. Clinical Predictors of Response to Magnetic Seizure Therapy in Depression: A Preliminary Report. The Journal of Ect. PMID 29613946 DOI: 10.1097/Yct.0000000000000495 |
0.425 |
|
| 2018 |
Bewernick BH, Kilian HM, Schmidt K, Reinfeldt RE, Kayser S, Coenen VA, Markett S, Schlaepfer TE. Deep brain stimulation of the supero-lateral branch of the medial forebrain bundle does not lead to changes in personality in patients suffering from severe depression. Psychological Medicine. 1-9. PMID 29493478 DOI: 10.1017/S0033291718000296 |
0.435 |
|
| 2018 |
Bewernick B, Rösner M, Kilian H, Klein M, Kayser S, Reuter M, Hurlemann R, Coenen V, Schlaepfer T. S151. Deep Brain Stimulation of the Medial Forebrain Bundle in Treatment-Resistant Depression- Criteria for Patient Selection Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1043 |
0.462 |
|
| 2018 |
Kilian H, Bewernick B, Coenen V, Schlaepfer T. S113. Unintended Discontinuation of Deep Brain Stimulation for Treatment-Resistant Depression: A Case Series Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.1004 |
0.447 |
|
| 2017 |
Beeker T, Schlaepfer TE, Coenen VA. Autonomy in Depressive Patients Undergoing DBS-Treatment: Informed Consent, Freedom of Will and DBS’ Potential to Restore It Frontiers in Integrative Neuroscience. 11: 11-11. PMID 28642690 DOI: 10.3389/Fnint.2017.00011 |
0.458 |
|
| 2017 |
Bewernick BH, Kayser S, Gippert SM, Switala C, Coenen VA, Schlaepfer TE. Deep brain stimulation to the medial forebrain bundle for depression- long-term outcomes and a novel data analysis strategy. Brain Stimulation. 10: 664-671. PMID 28259544 DOI: 10.1016/J.Brs.2017.01.581 |
0.468 |
|
| 2017 |
Bewernick BH, Urbach AS, Bröder A, Kayser S, Schlaepfer TE. Walking away from depression-motor activity increases ratings of mood and incentive drive in patients with major depression. Psychiatry Research-Neuroimaging. 247: 68-72. PMID 27865100 DOI: 10.1016/J.Psychres.2016.09.009 |
0.36 |
|
| 2017 |
Bewernick BH, Kayser S, Gippert SM, Coenen VA, Schlaepfer TE. Acute antidepressant effects of deep brain stimulation – Review and data from slMFB-stimulation Personalized Medicine in Psychiatry. 3: 1-7. DOI: 10.1016/J.Pmip.2017.01.002 |
0.401 |
|
| 2017 |
Coenen VA, Schlaepfer TE, Bewernick B, Bostroem J, Hattingen E, Urbach H, Li M. Diffusion tensor magnetic resonance imaging tractographic analysis of slMFB DBS in major depression Brain Stimulation. 10: 523-524. DOI: 10.1016/J.Brs.2017.01.527 |
0.342 |
|
| 2017 |
Schlaepfer T, Coenen V, Bewernick B. 719. Deep Brain Stimulation for Treatment Resistant Depression – Where Are We Coming From? Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.786 |
0.459 |
|
| 2016 |
Coenen VA, Schlaepfer TE, Goll P, Reinacher PC, Voderholzer U, Tebartz van Elst L, Urbach H, Freyer T. The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder. Cns Spectrums. 1-8. PMID 27268576 DOI: 10.1017/S1092852916000286 |
0.428 |
|
| 2016 |
Allert N, Gippert SM, Sajonz BE, Nelles C, Bewernick B, Schlaepfer TE, Coenen VA. Arachnophobia alleviated by subthalamic nucleus stimulation for Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 123: 631-5. PMID 27198699 DOI: 10.1007/S00702-016-1546-1 |
0.309 |
|
| 2016 |
Gippert SM, Switala C, Bewernick BH, Kayser S, Bräuer A, Coenen VA, Schlaepfer TE. Deep brain stimulation for bipolar disorder-review and outlook. Cns Spectrums. 1-4. PMID 26863160 DOI: 10.1017/S1092852915000577 |
0.485 |
|
| 2015 |
Bewernick B, Schlaepfer TE. Update on Neuromodulation for Treatment-Resistant Depression. F1000research. 4. PMID 26918135 DOI: 10.12688/F1000Research.6633.1 |
0.489 |
|
| 2015 |
Schlaepfer TE. Deep Brain Stimulation for Major Depression-Steps on a Long and Winding Road. Biological Psychiatry. 78: 218-9. PMID 26195174 DOI: 10.1016/J.Biopsych.2015.06.020 |
0.397 |
|
| 2015 |
Evens R, Stankevich Y, Dshemuchadse M, Storch A, Wolz M, Reichmann H, Schlaepfer TE, Goschke T, Lueken U. The impact of Parkinson's disease and subthalamic deep brain stimulation on reward processing. Neuropsychologia. 75: 11-9. PMID 25976111 DOI: 10.1016/J.Neuropsychologia.2015.05.005 |
0.312 |
|
| 2015 |
Hurlemann R, Arndt S, Schlaepfer TE, Reul J, Maier W, Scheele D. Diminished appetitive startle modulation following targeted inhibition of prefrontal cortex. Scientific Reports. 5: 8954. PMID 25752944 DOI: 10.1038/Srep08954 |
0.353 |
|
| 2015 |
Levkovitz Y, Isserles M, Padberg F, Lisanby SH, Bystritsky A, Xia G, Tendler A, Daskalakis ZJ, Winston JL, Dannon P, Hafez HM, Reti IM, Morales OG, Schlaepfer TE, Hollander E, et al. Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 14: 64-73. PMID 25655160 DOI: 10.1002/Wps.20199 |
0.457 |
|
| 2015 |
Kayser S, Bewernick BH, Matusch A, Hurlemann R, Soehle M, Schlaepfer TE. Magnetic seizure therapy in treatment-resistant depression: Clinical, neuropsychological and metabolic effects Psychological Medicine. 45: 1073-1092. PMID 25420474 DOI: 10.1017/S0033291714002244 |
0.449 |
|
| 2015 |
Polster JD, Kayser S, Bewernick BH, Hurlemann R, Schlaepfer TE. Effects of electroconvulsive therapy and magnetic seizure therapy on acute memory retrieval. The Journal of Ect. 31: 13-9. PMID 24853650 DOI: 10.1097/Yct.0000000000000130 |
0.38 |
|
| 2014 |
Schlaepfer TE, Bewernick BH, Kayser S, Hurlemann R, Coenen VA. Deep brain stimulation of the human reward system for major depression--rationale, outcomes and outlook. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1303-14. PMID 24513970 DOI: 10.1038/Npp.2014.28 |
0.467 |
|
| 2014 |
George MS, Schlaepfer T, Padberg F, Fitzgerald PB. Brain stimulation treatments for depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 167-8. PMID 24506290 DOI: 10.3109/15622975.2013.869619 |
0.47 |
|
| 2014 |
Soehle M, Kayser S, Ellerkmann RK, Schlaepfer TE. Bilateral bispectral index monitoring during and after electroconvulsive therapy compared with magnetic seizure therapy for treatment-resistant depression Bja: British Journal of Anaesthesia. 112: 695-702. PMID 24305645 DOI: 10.1093/Bja/Aet410 |
0.342 |
|
| 2014 |
Schlaepfer TE, Bewernick BH. Neuromodulation for treatment resistant depression: state of the art and recommendations for clinical and scientific conduct. Brain Topography. 27: 12-9. PMID 24072617 DOI: 10.1007/S10548-013-0315-9 |
0.474 |
|
| 2014 |
Panksepp J, Wright JS, Döbrössy MD, Schlaepfer TE, Coenen VA. Affective neuroscience strategies for understanding and treating depression: From preclinical models to three novel therapeutics Clinical Psychological Science. 2: 472-494. DOI: 10.1177/2167702614535913 |
0.369 |
|
| 2013 |
Schlaepfer TE, Bewernick BH. Deep brain stimulation for major depression. Handbook of Clinical Neurology. 116: 235-243. PMID 24112897 DOI: 10.1016/B978-0-444-53497-2.00018-8 |
0.453 |
|
| 2013 |
de Zwaan M, Schlaepfer TE. Not too much reason for excitement: deep brain stimulation for anorexia nervosa. European Eating Disorders Review : the Journal of the Eating Disorders Association. 21: 509-11. PMID 24038863 DOI: 10.1002/Erv.2258 |
0.303 |
|
| 2013 |
Coenen VA, Mädler B, Schlaepfer TE. Reply to: medial forebrain bundle stimulation-speed access to an old or entry into a new depression neurocircuit? Biological Psychiatry. 74: e45-6. PMID 23916389 DOI: 10.1016/J.Biopsych.2013.06.017 |
0.414 |
|
| 2013 |
Kayser S, Bewernick BH, Hurlemann R, Soehle M, Schlaepfer TE. Comparable seizure characteristics in magnetic seizure therapy and electroconvulsive therapy for major depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1541-50. PMID 23820052 DOI: 10.1016/J.Euroneuro.2013.04.011 |
0.354 |
|
| 2013 |
Schlaepfer TE, Bewernick BH, Kayser S, Mädler B, Coenen VA. Rapid effects of deep brain stimulation for treatment-resistant major depression. Biological Psychiatry. 73: 1204-12. PMID 23562618 DOI: 10.1016/J.Biopsych.2013.01.034 |
0.472 |
|
| 2013 |
Schlaepfer T. 3035 – The magnitude of the problem - what price is society paying for under diagnosis and sub optimal treatment of depression European Psychiatry. 28: 1. DOI: 10.1016/S0924-9338(13)77529-1 |
0.373 |
|
| 2012 |
Coenen VA, Schlaepfer TE, Allert N, Mädler B. Diffusion tensor imaging and neuromodulation: DTI as key technology for deep brain stimulation. International Review of Neurobiology. 107: 207-34. PMID 23206684 DOI: 10.1016/B978-0-12-404706-8.00011-5 |
0.325 |
|
| 2012 |
Schaefer M, Sarkar R, Knop V, Effenberger S, Friebe A, Heinze L, Spengler U, Schlaepfer T, Reimer J, Buggisch P, Ockenga J, Link R, Rentrop M, Weidenbach H, Fromm G, et al. Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial. Annals of Internal Medicine. 157: 94-103. PMID 22801672 DOI: 10.7326/0003-4819-157-2-201207170-00006 |
0.378 |
|
| 2012 |
Holtzheimer PE, Kosel M, Schlaepfer T. Brain stimulation therapies for neuropsychiatric disease. Handbook of Clinical Neurology. 106: 681-95. PMID 22608652 DOI: 10.1016/B978-0-444-52002-9.00041-3 |
0.458 |
|
| 2012 |
Bewernick BH, Kayser S, Sturm V, Schlaepfer TE. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1975-85. PMID 22473055 DOI: 10.1038/Npp.2012.44 |
0.438 |
|
| 2012 |
Schlaepfer TE, Agren H, Monteleone P, Gasto C, Pitchot W, Rouillon F, Nutt DJ, Kasper S. The hidden third: improving outcome in treatment-resistant depression. Journal of Psychopharmacology (Oxford, England). 26: 587-602. PMID 22236505 DOI: 10.1177/0269881111431748 |
0.439 |
|
| 2012 |
Synofzik M, Fins JJ, Schlaepfer TE. A neuromodulation experience registry for deep brain stimulation studies in psychiatric research: rationale and recommendations for implementation. Brain Stimulation. 5: 653-5. PMID 22100456 DOI: 10.1016/J.Brs.2011.10.003 |
0.346 |
|
| 2012 |
Kayser S, Bewernick BH, Schlaepfer TE. Clinical and cognitive effects of magnetic seizure therapy for treatment resistant depression F1000research. 3. DOI: 10.7490/F1000Research.1090252.1 |
0.391 |
|
| 2012 |
Schlaepfer TE. Toward an Emergent Consensus–International Perspectives on Neuroethics of Deep Brain Stimulation for Psychiatric Disorders–A Tower of Babel? Ajob Neuroscience. 3: 1-3. DOI: 10.1080/21507740.2012.646914 |
0.366 |
|
| 2012 |
Synofzik M, Schlaepfer TE, Fins JJ. How Happy Is Too Happy? Euphoria, Neuroethics, and Deep Brain Stimulation of the Nucleus Accumbens Ajob Neuroscience. 3: 30-36. DOI: 10.1080/21507740.2011.635633 |
0.359 |
|
| 2012 |
Kayser S, Bewernick BH, Hurlemann R, Schlaepfer TE. P.2.a.026 Significant clinical, cognitive and imaging findings of bilateral magnetic seizure therapy in 26 treatment-resistant depression patients European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70355-3 |
0.396 |
|
| 2012 |
Kayser S, Bewernick BH, Hurlemann R, Schlaepfer TE. P.2.a.025 Similar seizure characteristics of electroconvulsive therapy and magnetic seizure therapy in treatment-resistant depression European Neuropsychopharmacology. 22. DOI: 10.1016/S0924-977X(12)70354-1 |
0.355 |
|
| 2011 |
Schlaepfer TE, Bewernick B, Kayser S, Lenz D. Modulating affect, cognition, and behavior - prospects of deep brain stimulation for treatment-resistant psychiatric disorders. Frontiers in Integrative Neuroscience. 5: 29. PMID 21738500 DOI: 10.3389/Fnint.2011.00029 |
0.42 |
|
| 2011 |
Grubert C, Hurlemann R, Bewernick BH, Kayser S, Hadrysiewicz B, Axmacher N, Sturm V, Schlaepfer TE. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 12: 516-27. PMID 21736514 DOI: 10.3109/15622975.2011.583940 |
0.454 |
|
| 2011 |
Fins JJ, Schlaepfer TE, Nuttin B, Kubu CS, Galert T, Sturm V, Merkel R, Mayberg HS. Ethical guidance for the management of conflicts of interest for researchers, engineers and clinicians engaged in the development of therapeutic deep brain stimulation. Journal of Neural Engineering. 8: 033001. PMID 21555849 DOI: 10.1088/1741-2560/8/3/033001 |
0.317 |
|
| 2011 |
Schmitz-Hübsch T, Coudert M, Tezenas du Montcel S, Giunti P, Labrum R, Dürr A, Ribai P, Charles P, Linnemann C, Schöls L, Rakowicz M, Rola R, Zdzienicka E, Fancellu R, Mariotti C, ... ... Schlaepfer TE, et al. Depression comorbidity in spinocerebellar ataxia. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 870-6. PMID 21437988 DOI: 10.1002/Mds.23698 |
0.41 |
|
| 2011 |
Wade AG, Crawford GM, Nemeroff CB, Schatzberg AF, Schlaepfer T, McConnachie A, Haazen L, Buntinx E. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Psychological Medicine. 41: 2089-97. PMID 21349239 DOI: 10.1017/S0033291711000158 |
0.354 |
|
| 2011 |
Kosel M, Brockmann H, Frick C, Zobel A, Schlaepfer TE. Chronic vagus nerve stimulation for treatment-resistant depression increases regional cerebral blood flow in the dorsolateral prefrontal cortex. Psychiatry Research. 191: 153-9. PMID 21306877 DOI: 10.1016/J.Pscychresns.2010.11.004 |
0.407 |
|
| 2011 |
Fins JJ, Mayberg HS, Nuttin B, Kubu CS, Galert T, Sturm V, Stoppenbrink K, Merkel R, Schlaepfer TE. Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Affairs (Project Hope). 30: 302-11. PMID 21289352 DOI: 10.1377/Hlthaff.2010.0157 |
0.33 |
|
| 2011 |
Synofzik M, Schlaepfer TE. Electrodes in the brain--ethical criteria for research and treatment with deep brain stimulation for neuropsychiatric disorders. Brain Stimulation. 4: 7-16. PMID 21255750 DOI: 10.1016/J.Brs.2010.03.002 |
0.422 |
|
| 2011 |
Coenen VA, Schlaepfer TE, Maedler B, Panksepp J. Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neuroscience and Biobehavioral Reviews. 35: 1971-81. PMID 21184778 DOI: 10.1016/J.Neubiorev.2010.12.009 |
0.355 |
|
| 2011 |
Kayser S, Bewernick BH, Grubert C, Hadrysiewicz BL, Axmacher N, Schlaepfer TE. Antidepressant effects, of magnetic seizure therapy and electroconvulsive therapy, in treatment-resistant depression. Journal of Psychiatric Research. 45: 569-76. PMID 20951997 DOI: 10.1016/J.Jpsychires.2010.09.008 |
0.445 |
|
| 2011 |
Kosel M, Bilkei-Gorzo A, Zawatzky R, Zimmer A, Schlaepfer TE. Pegylated human interferon alpha 2a does not induce depression-associated changes in mice. Psychiatry Research. 185: 243-7. PMID 20580843 DOI: 10.1016/J.Psychres.2009.10.012 |
0.326 |
|
| 2011 |
Kayser S, Bewernick BH, Lenz D, Hurlemann R, Soehle M, Schlaepfer TE. P.2.e.014 Effects of magnetic seizure therapy in patients with treatment resistant depression European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70687-3 |
0.399 |
|
| 2010 |
Bajbouj M, Merkl A, Schlaepfer TE, Frick C, Zobel A, Maier W, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, et al. Two-year outcome of vagus nerve stimulation in treatment-resistant depression. Journal of Clinical Psychopharmacology. 30: 273-81. PMID 20473062 DOI: 10.1097/Jcp.0B013E3181Db8831 |
0.418 |
|
| 2010 |
Schlaepfer TE, Lisanby SH, Pallanti S. Separating hope from hype: some ethical implications of the development of deep brain stimulation in psychiatric research and treatment. Cns Spectrums. 15: 285-7. PMID 20448518 DOI: 10.1017/S1092852900027504 |
0.318 |
|
| 2010 |
Schlaepfer TE, Fins JJ. Deep brain stimulation and the neuroethics of responsible publishing: when one is not enough. Jama. 303: 775-6. PMID 20179289 DOI: 10.1001/Jama.2010.140 |
0.353 |
|
| 2010 |
Schlaepfer TE, George MS, Mayberg H. WFSBP Guidelines on Brain Stimulation Treatments in Psychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 11: 2-18. PMID 20146648 DOI: 10.3109/15622970903170835 |
0.325 |
|
| 2010 |
Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B, Axmacher N, Lemke M, Cooper-Mahkorn D, Cohen MX, Brockmann H, Lenartz D, Sturm V, Schlaepfer TE. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biological Psychiatry. 67: 110-6. PMID 19914605 DOI: 10.1016/J.Biopsych.2009.09.013 |
0.475 |
|
| 2010 |
Pallanti S, Schlaepfer TE, Lisanby SH. The clinical future of repetitive transcranial magnetic stimulation and depression: Separating hope from hype Cns Spectrums. 15: 554-557. DOI: 10.1017/S1092852900000523 |
0.426 |
|
| 2010 |
Wade A, Nemeroff C, Schatzberg A, Schlaepfer T, Haazen L, Buntinx E. P03-383 - Addition of a selective 5-HT2A/D4 antagonist accelerates the antidepressant effects of citalopram European Psychiatry. 25: 999. DOI: 10.1016/S0924-9338(10)70989-5 |
0.301 |
|
| 2010 |
Schlaepfer TE, Fins JJ. Registering Findings From Deep Brain Stimulation—Reply Jama. 303: 2139-2140. DOI: 10.1001/Jama.2010.706 |
0.311 |
|
| 2009 |
George MS, Padberg F, Schlaepfer TE, O'Reardon JP, Fitzgerald PB, Nahas ZH, Marcolin MA. Controversy: Repetitive transcranial magnetic stimulation or transcranial direct current stimulation shows efficacy in treating psychiatric diseases (depression, mania, schizophrenia, obsessive-complusive disorder, panic, posttraumatic stress disorder). Brain Stimulation. 2: 14-21. PMID 20633399 DOI: 10.1016/J.Brs.2008.06.001 |
0.443 |
|
| 2009 |
Rabins P, Appleby BS, Brandt J, DeLong MR, Dunn LB, Gabriëls L, Greenberg BD, Haber SN, Holtzheimer PE, Mari Z, Mayberg HS, McCann E, Mink SP, Rasmussen S, Schlaepfer TE, et al. Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Archives of General Psychiatry. 66: 931-7. PMID 19736349 DOI: 10.1001/Archgenpsychiatry.2009.113 |
0.392 |
|
| 2009 |
Schmitz-Hübsch T, Schlaepfer TE, Westheide J, von Falkenhausen M, Cooper-Mahkorn D, Maier W, Kühn KU. Clozapine: acquittal of the usual suspect. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 981-4. PMID 19711227 DOI: 10.1080/15622970903186229 |
0.306 |
|
| 2009 |
Kilts CD, Wade AG, Andersen HF, Schlaepfer TE. Baseline severity of depression predicts antidepressant drug response relative to escitalopram. Expert Opinion On Pharmacotherapy. 10: 927-36. PMID 19317630 DOI: 10.1517/14656560902849258 |
0.397 |
|
| 2009 |
Kayser S, Bewernick B, Axmacher N, Schlaepfer TE. Magnetic seizure therapy of treatment-resistant depression in a patient with bipolar disorder. The Journal of Ect. 25: 137-40. PMID 19057399 DOI: 10.1097/Yct.0B013E31817Dc45A |
0.43 |
|
| 2009 |
Wade AG, Schlaepfer TE, Andersen HF, Kilts CD. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD). Journal of Psychiatric Research. 43: 568-75. PMID 18954875 DOI: 10.1016/J.Jpsychires.2008.09.008 |
0.355 |
|
| 2009 |
Kayser S, Bewernick BH, Grubert C, Hadrysiewicz B, Koch A, Bley JG, Axmacher N, Schlaepfer T. P.2.a.040 Effects of magnetic seizure therapy and electroconvulsive therapy in treatment-resistant depression European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70589-9 |
0.38 |
|
| 2009 |
Schlaepfer TE, Bewernick HE, Kayser S, Lenartz D, Sturm V. S.02.05 Deep brain stimulation for treatment resistant depression – predictors of response European Neuropsychopharmacology. 19. DOI: 10.1016/S0924-977X(09)70198-1 |
0.451 |
|
| 2008 |
Synofzik M, Schlaepfer TE. Stimulating personality: ethical criteria for deep brain stimulation in psychiatric patients and for enhancement purposes. Biotechnology Journal. 3: 1511-20. PMID 19072907 DOI: 10.1002/Biot.200800187 |
0.416 |
|
| 2008 |
Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, et al. Vagus nerve stimulation for depression: efficacy and safety in a European study. Psychological Medicine. 38: 651-61. PMID 18177525 DOI: 10.1017/S0033291707001924 |
0.434 |
|
| 2008 |
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AY, Kreft M, Lenartz D, Sturm V. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 368-77. PMID 17429407 DOI: 10.1038/Sj.Npp.1301408 |
0.481 |
|
| 2008 |
Schlaepfer TE, Frick C, Zobel A, Maier W, Heuser I, Bajbouj M, O'Keane V, Corcoran C, Adolfsson R, Trimble M, Rau H, Hoff HJ, Padberg F, Müller-Siecheneder F, Audenaert K, et al. Vagus nerve stimulation for depression: Efficacy and safety in a European study (Psychological Medicine (2008) 38, (651-661) DOI: 10.1017/ S0033291707001924) Psychological Medicine. 38: 1067. DOI: 10.1017/S0033291708003528 |
0.37 |
|
| 2008 |
Wade A, Kilts C, Schlaepfer T. P.2.a.003 Baseline severity of depression predicts antidepressant drug response European Neuropsychopharmacology. 18: S294. DOI: 10.1016/S0924-977X(08)70392-4 |
0.349 |
|
| 2008 |
Wade A, Schlaepfer T, Kilts C. P.2.a.002 Treatment milestones predict symptom remission over 6-month treatment of patients with major depressive disorder (MDD) European Neuropsychopharmacology. 18: S293-S294. DOI: 10.1016/S0924-977X(08)70391-2 |
0.401 |
|
| 2007 |
Kosel M, Sturm V, Frick C, Lenartz D, Zeidler G, Brodesser D, Schlaepfer TE. Mood improvement after deep brain stimulation of the internal globus pallidus for tardive dyskinesia in a patient suffering from major depression. Journal of Psychiatric Research. 41: 801-3. PMID 16962613 DOI: 10.1016/J.Jpsychires.2006.07.010 |
0.489 |
|
| 2007 |
Frick C, Kayser S, Bewernick B, Axmacher N, Schlaepfer TE. P.2.c.031 Two-year outcome of vagus nerve stimulation (VNS) in a sample of treatment-resistant depressive patients European Neuropsychopharmacology. 17. DOI: 10.1016/S0924-977X(07)70523-0 |
0.383 |
|
| 2006 |
Lieb K, Schlaepfer TE. Deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 355: 2256; author reply 2. PMID 17124028 DOI: 10.1056/Nejmc062545 |
0.322 |
|
| 2006 |
Wagner M, Rihs TA, Mosimann UP, Fisch HU, Schlaepfer TE. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex affects divided attention immediately after cessation of stimulation. Journal of Psychiatric Research. 40: 315-21. PMID 16055155 DOI: 10.1016/J.Jpsychires.2005.06.001 |
0.361 |
|
| 2006 |
Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, Fisch HU, Pearlson GD. Decreased frontal white-matter volume in chronic substance abuse. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 147-53. PMID 16004619 DOI: 10.1017/S1461145705005705 |
0.315 |
|
| 2006 |
Frick C, Hosten S, Brodesser D, Kosel M, Axmacher N, Kuehn KU, Brannan S, Maier W, Schlaepfer TE. P.2.g.004 Severity of depression during the first year of vagus nerve stimulation in the group of non-responders European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70421-7 |
0.367 |
|
| 2006 |
Frick C, Hosten S, Kosel M, Brodesser D, Axmacher N, Kuehn KU, Brannan S, Kreft M, Zobel A, Maier W, Schlaepfer TE. P.2.a.024 Results of the European multi-centre study (D03) of vagus nerve stimulation in treatment-resistant depressive patients European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70304-2 |
0.399 |
|
| 2006 |
Schlaepfer TE, Kosel M, Fisch HU. Repetitive transcranial magnetic stimulation (rTMS) in depression Poiesis & Praxis. 4: 111-127. DOI: 10.1007/S10202-005-0019-7 |
0.451 |
|
| 2005 |
Schlaepfer TE, Lieb K. Deep brain stimulation for treatment of refractory depression Lancet. 366: 1420-1422. PMID 16243078 DOI: 10.1016/S0140-6736(05)67582-4 |
0.476 |
|
| 2005 |
Schulze-Rauschenbach SC, Harms U, Schlaepfer TE, Maier W, Falkai P, Wagner M. Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression. The British Journal of Psychiatry : the Journal of Mental Science. 186: 410-6. PMID 15863746 DOI: 10.1192/Bjp.186.5.410 |
0.447 |
|
| 2004 |
Mosimann UP, Schmitt W, Greenberg BD, Kosel M, Müri RM, Berkhoff M, Hess CW, Fisch HU, Schlaepfer TE. Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients. Psychiatry Research. 126: 123-33. PMID 15123391 DOI: 10.1016/J.Psychres.2003.10.006 |
0.472 |
|
| 2004 |
Kosel M, Rudolph U, Wielepp P, Luginbühl M, Schmitt W, Fisch HU, Schlaepfer TE. Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 347-50. PMID 14628001 DOI: 10.1038/Sj.Npp.1300353 |
0.336 |
|
| 2004 |
Schlaepfer T, Kosel M. Novel physical treatments for major depression: vagus nerve stimulation, transcranial magnetic stimulation and magnetic seizure therapy Current Opinion in Psychiatry. 17: 15-20. DOI: 10.1097/00001504-200401000-00004 |
0.46 |
|
| 2004 |
Kosel M, Rudolph U, Wielepp P, Luginbuhl M, Schmitt W, Fisch HU, Schlaepfer TE. Erratum: Diminished GABAA receptor binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety (Neuropsychopharmacology (2004) 29 (347-350) DOI: 10.1038/sj.npp.1300353) Neuropsychopharmacology. 29. DOI: 10.1038/Sj.Npp.1300447 |
0.359 |
|
| 2003 |
Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE. Magnetic seizure therapy improves mood in refractory major depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 2045-8. PMID 12942146 DOI: 10.1038/Sj.Npp.1300293 |
0.47 |
|
| 2003 |
Kosel M, Schlaepfer TE. Beyond the treatment of epilepsy: new applications of vagus nerve stimulation in psychiatry. Cns Spectrums. 8: 515-21. PMID 12894032 DOI: 10.1017/S1092852900018988 |
0.443 |
|
| 2003 |
Belmaker B, Fitzgerald P, George MS, Lisanby SH, Pascual-Leone A, Schlaepfer TE, Wassermann E. Managing the risks of repetitive transcranial stimulation. Cns Spectrums. 8: 489. PMID 12894029 DOI: 10.1017/S1092852900018952 |
0.382 |
|
| 2003 |
Lisanby SH, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of magnetic seizure therapy (MST) in major depression: randomized within-subject comparison with electroconvulsive therapy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1852-65. PMID 12865903 DOI: 10.1038/Sj.Npp.1300229 |
0.371 |
|
| 2003 |
George MS, Nahas Z, Lisanby SH, Schlaepfer T, Kozel FA, Greenberg BD. Transcranial magnetic stimulation. Neurosurgery Clinics of North America. 14: 283-301. PMID 12856495 DOI: 10.1016/S1042-3680(02)00120-1 |
0.373 |
|
| 2003 |
Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Pérez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. The British Journal of Psychiatry : the Journal of Mental Science. 182: 480-91. PMID 12777338 DOI: 10.1192/Bjp.182.6.480 |
0.438 |
|
| 2003 |
Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 201-5. PMID 12589372 DOI: 10.1038/Sj.Npp.1300038 |
0.424 |
|
| 2003 |
Schlaepfer TE. Progress in Therapeutic Brain Stimulation in Neuropsychiatry Cns Spectrums. 8: 488-488. DOI: 10.1017/S1092852900018940 |
0.363 |
|
| 2002 |
Kosel M, Schlaepfer TE. Mechanisms and state of the art of vagus nerve stimulation. The Journal of Ect. 18: 189-92. PMID 12468993 DOI: 10.1097/00124509-200212000-00004 |
0.411 |
|
| 2002 |
Mosimann UP, Marré SC, Werlen S, Schmitt W, Hess CW, Fisch HU, Schlaepfer TE. Antidepressant effects of repetitive transcranial magnetic stimulation in the elderly: correlation between effect size and coil-cortex distance. Archives of General Psychiatry. 59: 560-1. PMID 12044199 DOI: 10.7892/Boris.43042 |
0.331 |
|
| 2002 |
Schlaepfer T, Lisanby H, Fisch H, Sackeim H. Magnetic seizure induction for the treatment of major depression European Psychiatry. 17: 43. DOI: 10.1016/S0924-9338(02)80192-4 |
0.395 |
|
| 2002 |
Schlaepfer TE, Kosel M, Frick-Schröter C, Fisch H-. An overview of the antidepressant properties of transcranial magnetic stimulation European Psychiatry. 17: 4. DOI: 10.1016/S0924-9338(02)80015-3 |
0.337 |
|
| 2001 |
Rodriguez‐Martin JL, Barbanoj JM, Schlaepfer T, Clos SS, Pérez V, Kulisevsky J, Gironell A. Transcranial magnetic stimulation for treating depression Cochrane Database of Systematic Reviews. 2002. PMID 12076483 DOI: 10.1002/14651858.Cd003493 |
0.45 |
|
| 2001 |
Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD, Wong SH. Cerebral blood flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Research. 108: 89-100. PMID 11738543 DOI: 10.1016/S0925-4927(01)00114-7 |
0.372 |
|
| 2001 |
Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic seizure therapy of major depression. Archives of General Psychiatry. 58: 303-5. PMID 11231838 DOI: 10.1001/Archpsyc.58.3.303 |
0.378 |
|
| 2000 |
Mosimann UP, Rihs TA, Engeler J, Fisch HU, Schlaepfer TE. Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers. Psychiatry Research-Neuroimaging. 94: 251-256. PMID 10889289 DOI: 10.1016/S0165-1781(00)00146-3 |
0.359 |
|
| 1998 |
Ji RR, Schlaepfer TE, Aizenman CD, Epstein CM, Qiu D, Huang JC, Rupp F. Repetitive transcranial magnetic stimulation activates specific regions in rat brain. Proceedings of the National Academy of Sciences of the United States of America. 95: 15635-40. PMID 9861022 DOI: 10.1073/Pnas.95.26.15635 |
0.434 |
|
| 1997 |
Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M, Wassermann EM, Post RM, Murphy DL. Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a preliminary study. The American Journal of Psychiatry. 154: 867-9. PMID 9167520 DOI: 10.1176/Ajp.154.6.867 |
0.36 |
|
| 1994 |
Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD. Decreased regional cortical gray matter volume in Schizophrenia American Journal of Psychiatry. 151: 842-848. PMID 8184992 DOI: 10.1176/Ajp.151.6.842 |
0.31 |
|
| Show low-probability matches. |